Geode Capital Management
NBTX

Geode Capital Management’s Nanobiotix NBTX Stock Holding History

Geode Capital Management’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,184
Closed -$192K – 4535
2025
Q3 		$192K Hold
10,184
– – ﹤0.01% 3935
2025
Q2 		$48.2K Hold
10,184
– – ﹤0.01% 4226
2025
Q1 		$36.1K Hold
10,184
– – ﹤0.01% 4252
2024
Q4 		$29.2K Buy
+10,184
New +$40.7K ﹤0.01% 4329

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Geode Capital Management's NBTX Position: Q4 2025 in Review

Geode Capital Management sold out of Nanobiotix (NBTX) in Q4 2025, closing a stake of 10,184 shares — an estimated $192K sold.

Geode Capital Management first reported a position in NBTX in Q4 2024 and held it in 4 quarters. The position peaked at $192K in Q3 2025. 14 funds tracked by Wall St. Rank hold NBTX as of Q4 2025.

  • Geode Capital Management reported no remaining Nanobiotix position as of Q4 2025 after selling out during the quarter.
  • Geode Capital Management sold 10,184 Nanobiotix shares in Q4 2025, an estimated $192K.
  • Geode Capital Management first reported a position in Nanobiotix in Q4 2024 and held it in 4 quarters.
  • Geode Capital Management's Nanobiotix position peaked at $192K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Nanobiotix as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.